FutureMeds - London

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials
• Type 2 diabetes2 trials
• COPD1 trial
• High blood pressure1 trial
• Osteoarthritis1 trial

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Recruiting3 trials
• Active, not recruiting2 trials

Lead sponsor

• Pfizer2 trials
• Altesa Biosciences, Inc.1 trial
• Boehringer Ingelheim1 trial
• Eli Lilly and Company1 trial

Running trials

• Recruiting

  Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD

  NCT07610395· Phase 2· Altesa Biosciences, Inc.· Source

  Contact: FutureMeds London

• Active, not recruiting

  A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

  NCT07400653· Phase 3· Pfizer· Source

• Recruiting

  Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  NCT07353931· Phase 3· Eli Lilly and Company· Source

  Contact: Pembe Ozunlu (principal investigator)

• Active, not recruiting

  Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity

  NCT07311850· Phase 3· Pfizer· Source

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD1 recruiting
• High blood pressure1 recruiting
• Obesity1 recruiting
• Osteoarthritis1 recruiting
• Type 2 diabetes1 recruiting